Showing results (1321-1330 of 2,755) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|September 14, 2021
Is olaparib cost effective in metastatic castration-resistant prostate cancer patients with at least one favorable gene mutation in BRCA1, BRCA2 or ATM?Yiyuan Li, Shen Lin, Lixian Zhong, et al.
Pharmacogenomics|November 16, 2022
Capecitabine-induced enterocolitis: a case report and pharmacogenetic profileTianyu Shao, Yao Zhang, Jiaping Liu, et al.
Pharmacogenomics|November 24, 2025
From genomics to clinic: the transformative impact of AI in pharmacogenomics and personalized medicineAnantha Lakshmi Jakka, Ripsy Merrin Chacko, Mallikarjun Vasam, et al.
Pharmacogenomics|October 14, 2025
Characterizing models for delivery of pharmacogenomic testing: a scoping reviewZeina Waheed, Mary Bunka, Louisa Edwards, et al.
Pharmacogenomics|June 23, 2020
Immunotherapy in non-small-cell lung cancer: from targeted molecules to resistance patternsSylvie Brassart-Pasco, Véronique Dalstein, Bertrand Brassart, et al.
Pharmacogenomics|September 15, 2021
Polymorphisms in the CYP3A5 gene significantly affect the pharmacokinetics of sirolimus after kidney transplantationJiawen Liu, Dengyuan Feng, Xuechun Kan, et al.
Pharmacogenomics|August 18, 2016
A review of consent practices and perspectives for pharmacogenetic testingSusanne B Haga, Rachel Mills
Pharmacogenomics|August 18, 2016
Polymorphisms in SLCO1B1 and UGT1A1 are associated with sorafenib-induced toxicitySander Bins, Anne Lenting, Samira El Bouazzaoui, et al.
Pharmacogenomics|April 15, 2020
Liquid biopsy for the detection of clinical biomarkers in early breast cancer: new insights and challengesAkiko Matsutani, Chihiro Udagawa, Yuki Matsunaga, et al.
Pharmacogenomics|September 19, 2025
How to implement pre-emptive pharmacogenetic testing in the acute hospital settingJohn Henry McDermott, Ali Shoaib, Jessica Keen, et al.
Pageof 276